JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)
China flag China · Delayed Price · Currency is CNY
26.12
+0.18 (0.69%)
At close: May 8, 2026

SHA:603235 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,36711,73711,14510,52412,748-
Market Cap Growth
-2.37%5.30%5.90%-17.45%--
Enterprise Value
10,14710,5839,5088,23012,181-
Last Close Price
26.1226.9724.9422.9927.17-
PE Ratio
21.9519.8417.1122.1220.49-
PS Ratio
4.805.015.055.595.53-
PB Ratio
2.242.392.422.493.14-
P/TBV Ratio
2.332.482.522.613.23-
P/FCF Ratio
185.98241.09-54.3636.83-
P/OCF Ratio
19.4318.6522.3114.4321.02-
EV/Sales Ratio
4.294.514.314.375.29-
EV/EBITDA Ratio
13.2412.0812.3515.1117.51-
EV/EBIT Ratio
17.8615.3515.3620.1321.29-
EV/FCF Ratio
166.02217.40-42.5135.19-
Debt / Equity Ratio
0.070.080.030.030.000.18
Debt / EBITDA Ratio
0.420.460.190.200.010.36
Debt / FCF Ratio
5.688.32-0.560.020.58
Net Debt / Equity Ratio
-0.24-0.24-0.31-0.52-0.56-0.19
Net Debt / EBITDA Ratio
-1.49-1.33-1.83-4.04-3.29-0.38
Net Debt / FCF Ratio
-19.96-23.932.49-11.36-6.62-0.61
Asset Turnover
0.390.400.410.390.600.86
Inventory Turnover
2.502.332.412.473.313.89
Quick Ratio
3.733.203.885.628.551.68
Current Ratio
5.084.385.296.7710.182.33
Return on Equity (ROE)
10.51%12.41%14.72%11.48%20.85%48.56%
Return on Assets (ROA)
6.47%7.31%7.24%5.23%9.37%18.39%
Return on Invested Capital (ROIC)
13.77%16.64%19.94%18.12%29.64%72.55%
Return on Capital Employed (ROCE)
11.00%12.40%12.20%8.80%13.10%37.90%
Earnings Yield
4.57%5.04%5.84%4.52%4.88%-
FCF Yield
0.54%0.41%-5.09%1.84%2.71%-
Dividend Yield
2.11%-2.73%2.17%2.61%-
Payout Ratio
58.85%51.53%33.81%65.66%1.10%118.09%
Buyback Yield / Dilution
0.19%-0.26%-0.11%-5.96%-4.68%0.10%
Total Shareholder Return
2.30%-0.26%2.61%-3.79%-2.06%0.10%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.